3OTQ | pdb_00003otq

Soluble Epoxide Hydrolase in complex with pyrazole antagonist


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free: 
    0.318 (Depositor), 0.312 (DCC) 
  • R-Value Work: 
    0.230 (Depositor), 0.225 (DCC) 

wwPDB Validation 3D Report Full Report

Validation slider image for 3OTQ

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domain.

Lo, H.Y.Man, C.C.Fleck, R.W.Farrow, N.A.Ingraham, R.H.Kukulka, A.Proudfoot, J.R.Betageri, R.Kirrane, T.Patel, U.Sharma, R.Hoermann, M.A.Kabcenell, A.Lombaert, S.D.

(2010) Bioorg Med Chem Lett 20: 6379-6383

  • DOI: https://doi.org/10.1016/j.bmcl.2010.09.095
  • Primary Citation Related Structures: 
    3OTQ

  • PubMed Abstract: 

    A novel series of pyrazole sEH inhibitors is reported. Lead optimization efforts to replace the aniline core are also described. In particular, 2-pyridine, 3-pyridine and pyridazine analogs are potent sEH inhibitors with favorable CYP3A4 inhibitory and microsomal stability profiles.


  • Organizational Affiliation
    • Boehringer Ingelheim Pharmaceuticals Inc., Biomolecular Screening, 900 Ridgebury Rd., PO Box 368, Ridgefield, CT 06877, USA. ho-yin.lo@boehringer-ingelheim.com

Macromolecule Content 

  • Total Structure Weight: 63.06 kDa 
  • Atom Count: 4,385 
  • Modeled Residue Count: 545 
  • Deposited Residue Count: 555 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Epoxide hydrolase 2555Homo sapiensMutation(s): 0 
Gene Names: EPHX2
EC: 3.3.2.10 (PDB Primary Data), 3.1.3.76 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P34913 (Homo sapiens)
Explore P34913 
Go to UniProtKB:  P34913
PHAROS:  P34913
GTEx:  ENSG00000120915 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP34913
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
MZL

Query on MZL



Download:Ideal Coordinates CCD File
B [auth A]N-[4-(5-ethyl-3-pyridin-3-yl-1H-pyrazol-1-yl)phenyl]pyridine-3-carboxamide
C22 H19 N5 O
CCAFHMPMIJBDRP-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free:  0.318 (Depositor), 0.312 (DCC) 
  • R-Value Work:  0.230 (Depositor), 0.225 (DCC) 
Space Group: P 65 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 92.993α = 90
b = 92.993β = 90
c = 243.651γ = 120
Software Package:
Software NamePurpose
CrystalCleardata collection
CNXrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2010-10-27 
  • Deposition Author(s): Farrow, N.A.

Revision History  (Full details and data files)

  • Version 1.0: 2010-10-27
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2021-02-24
    Changes: Derived calculations
  • Version 1.3: 2024-02-21
    Changes: Data collection, Database references